Pacira BioSciences Inc. share price logo

Pacira BioSciences Inc.

NASDAQ: PCRX

Small Cap

$25.37

+0.28

(+1.12%)

as on

Pacira BioSciences Inc. Stock Performance

as on July 1, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $24.66
    $26.21
    downward going graph

    2.80%

    Downside

    3.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $18.80
    $27.64
    downward going graph

    25.90%

    Downside

    8.95%

    Upside

    downward going graph

Pacira BioSciences Inc. share price movements today

Previous Close
$25.09
Open
$26.00
Volume
504.9K
Day's Low - High
$24.66 - $26.21
52 Week Low - High
$18.80 - $27.64

Pacira BioSciences Inc. Historical Returns

1 Month Return
+ 10.5 %
3 Month Return
+ 11.32 %
1 Year Return
+ 9.12 %
3 Year Return
-36.69 %
5 Year Return
-57.7 %

Pacira BioSciences Inc. Stock Fundamentals & Key Indicators

Check Pacira BioSciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$993.1M

EPS (TTM)

2.877

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.30%

PE Ratio (TTM)

194.15

Industry PE ratio

-3.111470588235294

PEG Ratio

11.2121

EBITDA

121.3M

Revenue (TTM)

734.9M

Profit Margin

0.70%

Return On Equity TTM

0.71%

Pacira BioSciences Inc. Stock Valuation

Track how Pacira BioSciences Inc. P/E has moved over time to understand its valuation trends.

Pacira BioSciences Inc. in the last 5 years

  • Overview

  • Trends

Lowest (5.36x)

September 30, 2024

Industry (-3.11x)

July 1, 2026

Today (194.15x)

July 1, 2026

Highest (23.01x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 194.15x

Pacira BioSciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pacira BioSciences Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$993.1M-57.7%194.150.70%NA
BUY$23.0B193.4%20.0540.62%NA
HOLD$18.9B7.66%NA-2.04%2.94%
BUY$41.1BNA19.0415.11%2.07%
BUY$31.9B-62.04%12.4728.04%2.6100000000000003%

Stock Returns calculator for Pacira BioSciences Inc. Stock including INR - Dollar returns

The Pacira BioSciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pacira BioSciences Inc. investment value today

Current value as on today

₹1,20,527

Returns

₹20,527

(+20.53%)

Returns from Pacira BioSciences Inc. Stock

₹9,118 (+9.12%)

Dollar Impact

₹11,408 (+11.41%)

Analyst Recommendation on Pacira BioSciences Inc. Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Pacira BioSciences Inc.. Average target price of $29.67

Pacira BioSciences Inc. Share Price Target

Get share price movements and forecasts by analysts on Pacira BioSciences Inc..

What analysts predicted

14.49%UPSIDE

Target Price

$29.67

Current Price

$25.37

Analyzed by

16 Analysts

Target

$29.67

Pacira BioSciences Inc. target price $29.67, a slight upside of 14.49% compared to current price of $25.37. According to 16 analysts rating.

Indian Investors' Interest in Pacira BioSciences Inc. Stock

Search interest for Pacira BioSciences Inc. Stock has increased by 56% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:56% versus previous 30 day period

Pacira BioSciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
181
167
178
168
187
168
181
179
196
177
Gross Profit
133
119
133
129
147
134
140
145
156
140
Operating Income
33
13
28
-139
24
1
8
6
3
4
EBITDA
54
34
58
-114
50
33
29
34
25
29
Interest Expense
3
3
3
4
3
4
4
3
3
3
Depreciation
18
18
18
20
21
21
27
21
21
21
Income Before Tax
33
13
36
-138
25
8
-1
9
0
4
Income Tax Expense
8
4
17
4
9
3
2
4
-1
2
Net Income
24
8
18
-143
16
4
-4
5
1
2
Net Profit Margin
13.72%
5.37%
10.61%
-85.11%
8.57%
2.85%
-2.68%
3.03%
0.83%
1.64%

Pacira BioSciences Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
276
286
337
421
429
541
666
674
700
726
Gross Profit
166
198
250
314
312
401
467
490
530
576
Operating Income
-32
-24
15
10
46
89
60
87
-73
33
EBITDA
-17
-10
33
30
63
113
140
154
29
122
Interest Expense
7
18
21
23
25
28
35
17
16
14
Depreciation
-
13
13
19
19
13
91
87
78
91
Income Before Tax
-37
-42
0
-10
20
56
13
61
-63
16
Income Tax Expense
0
0
0
0
-125
14
-2
19
36
9
Net Income
-37
-42
0
-11
145
41
15
41
-99
7
Net Profit Margin
-13.73%
-14.87%
-0.14%
-2.62%
33.87%
7.75%
2.39%
6.22%
-14.20%
0.97%

Pacira BioSciences Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
8
18
-143
16
4
-4
5
1
2
Operating Cash Flow
49
53
53
33
35
12
60
43
25
Investing Cash Flow
-15
-15
-52
0
-25
62
43
19
19
Financing Cash Flow
-2
24
-2
-1
-2
-57
-257
-51
-59
Change in Cash
30
63
-1
30
6
16
-152
10
-14

Pacira BioSciences Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-42
0
-11
145
41
15
41
-99
7
Operating Cash Flow
17
48
70
77
125
145
154
189
151
Investing Cash Flow
-223
20
-128
-277
-20
-225
77
-83
99
Financing Cash Flow
224
8
3
222
380
-401
-183
17
-369
Change in Cash
18
78
-54
21
485
-481
49
123
-118

Global Institutional Holdings in Pacira BioSciences Inc.

Funds
Holdings
Two Sigma Investments LLC
1.34%
Bridgeway Capital Management, LLC
1.12%
D. E. Shaw & Co LP
5.04%
State Street Corp
4.88%
Goldman Sachs Group Inc
2.91%

Pacira BioSciences Inc. News & Key Events

  • img

    Today's Timeline - 30 June

    Tue, 05:00 PM

    -

    Pacira announces divestiture of iovera° to Zimmer Biomet for up to $140 million, enhancing its biopharmaceutical focus.

Insights on Pacira BioSciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PCRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PCRX stock has moved up by 5.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 1.63M → 2.91M (in $), with an average increase of 43.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 105.2% return, outperforming this stock by 96.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 196.87M → 177.37M (in $), with an average decrease of 9.9% per quarter

About Pacira BioSciences Inc.

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.
OrganisationPacira BioSciences Inc.
Headquarters2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Frank D. Lee
E-voting on sharesClick here to vote

Key Management of Pacira BioSciences Inc.

Name

Title

Mr. Anthony Molloy III, Esq.

Chief Legal & Compliance Officer

Mr. Frank D. Lee

CEO & Director

Ms. Kristen Williams Esq., J.D.

Chief Administrative Officer & Secretary

Mr. Brendan P. Teehan

Chief Commercial Officer

Ms. Lauren Bullaro Riker

Principal Accounting Officer & Senior VP of Finance

Ms. Susan Mesco

Head of Investor Relations

Mr. Christopher C. Young

Chief Manufacturing Officer

Ms. Krys Corbett Esq.

Chief Business Officer

Mr. Shawn M. Cross

Chief Financial Officer

Dr. Jonathan Slonin M.D.

Chief Medical Officer

FAQs

What is Pacira BioSciences Inc. share price today?

Pacira BioSciences Inc. share price today is $25.37 as on at the close of the market. Pacira BioSciences Inc. share today touched a day high of $26.21 and a low of $24.66.

What is the 52 week high and 52 week low for Pacira BioSciences Inc. share?

Pacira BioSciences Inc. share touched a 52 week high of $27.64 on and a 52 week low of $18.8 on . Pacira BioSciences Inc. stock price today i.e. is closed at $25.37,which is 8.21% down from its 52 week high and 34.95% up from its 52 week low.

What is Pacira BioSciences Inc.'s market capitalisation today?

Pacira BioSciences Inc. market capitalisation is $0.00T as on .

How to invest in Pacira BioSciences Inc. Stock (PCRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pacira BioSciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pacira BioSciences Inc. Shares that will get you 0.0591 shares as per Pacira BioSciences Inc. share price of $25.37 per share as on July 1, 2026 at 8:46 am IST.

What is the minimum amount required to buy Pacira BioSciences Inc. Stock (PCRX) from India?

Indian investors can start investing in Pacira BioSciences Inc. (PCRX) shares with as little as ₹94.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.60 in Pacira BioSciences Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Pacira BioSciences Inc. share’s latest price of $25.37 as on July 1, 2026 at 8:46 am IST, you will get 0.3942 shares of Pacira BioSciences Inc.. Learn more about fractional shares .

What are the returns that Pacira BioSciences Inc. has given to Indian investors in the last 5 years?

Pacira BioSciences Inc. stock has given -57.7% share price returns and 27.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?